Greater China Strategy | Alpha Picks: November Conviction Calls HSI and MSCI China fell 3.5%/4.0% mom in October, dragged by renewed US-China trade tensions and lack of fresh policy signals from the 4th Plenum. We remain constructive in the medium term but expect further consolidation as uncertainties persist. The best performer among our picks was SELL-rated Li Auto (+21.4% mom). For November, we rotate into oversold names with near-term upside: add AIA, LINK REIT, NAURA, Pinduoduo, PICC P&C an...
CSCEC’s 3Q25 attributable net profit declined 24.1% yoy, due to the weaker infrastructure and property segments, and less government grants. However, 9M25 still showed improved OCF and lower net gearing. We lower 2025/26/27 earnings by 6.1%/3.9%/2.2% to factor in lower property development margin and thus trim our target price by 6.8% to Rmb6.11. Maintain BUY. The company’s strategy of further enhancing cash collection and revenue recognition in 4Q25 will be a focus.
Top Stories Company Update | AIA Group (1299 HK/BUY/HK$75.45/Target: HK$95.00) AIA’s VONB grew strongly by 27% yoy in 3Q25, significantly above consensus expectation of 17% yoy, due to the sustained strong momentum in Hong Kong (+40% yoy) and a notable recovery in mainland China, where VONB rose 27% yoy despite assumption changes. ANP sales growth accelerated to 15% and VONB margin also improved 6.0ppt, due to a favourable shift in product mix in China. Maintain BUY with a higher target price o...
Greater China Strategy | Alpha Picks: October Conviction Calls The HSI and MSCI China gained 7.1%/8.2% mom in September on Fed easing and optimism over advancements in semiconductors and AI. We remain positive in the medium term but expect near-term consolidation after the recent strong gains. The best performer of the month was Alibaba (+53.0% mom). With some rotations expected in non-tech stocks, our October calls are: add Galaxy, Jacobson, Ping An, Trip.com and WuXi Bio to BUY; SELL Meituan. ...
The HSI and MSCI China gained 7.1%/8.2% mom in September on Fed easing and optimism over advancements in semiconductors and AI. We remain positive in the medium term but expect near-term consolidation after the recent strong gains. The best performer of the month was Alibaba (+53.0% mom). With some rotations expected in non-tech stocks, our October calls are: add Galaxy, Jacobson, Ping An, Trip.com and WuXi Bio to BUY; SELL Meituan. Take profits on Alibaba and Xiaomi; cut losses on Anta.
In August, the HSI and MSCI China Index hit their ytd highs, posting gains of 1.2% mom and 4.2% mom respectively, supported by dovish remarks from Fed Chair J. Powell at Jackson Hole. Looking ahead, we expect some consolidation as most of the positives have been priced in and are biased to SELL. We add Anta, BYDE and CSCEC to our BUY list, while initiating SELL calls on Li Auto and OOIL. We take profit on Innovent, JD Logistics, Lenovo, Sino Biopharm, Tencent and TME.
GREATER CHINA Strategy Alpha Picks: September Conviction Calls: Add Anta, BYDE and CSCEC to our BUY list, Li Auto and OOIL to our SELL list. Take profit on Innovent, JD Logistics, Lenovo, Sino Biopharm, Tencent and TME. INDONESIA Strategy Alpha Picks: Underperformance In August: Our new Alpha Picks are ASSA, ARCI, BBCA, BBNI, BRMS, MTEL, HRUM and NCKL. MALAYSIA Strategy Alpha Picks: Wake Me Up When September Ends: Our Aug 25 Alpha Picks underperformed marginally. Sep 25 picks: Alpha IVF, Hume ...
CSCEC’s attributable net profit grew 3.2% yoy in 1H25, meeting expectations, supported by lower asset impairment, lower finance cost and disposal gains, despite a 3.2% revenue decline. Improvement in OCF and growth of new pillars (industrial construction, energy engineering) are key highlights. Management remains focused on further improving OCF, shareholder returns (steady DPS, stake increase) and asset revitalisation. Maintain BUY with an unchanged target price of Rmb6.56.
GREATER CHINA Results Alibaba Group (9988 HK/BUY/HK$115.70/Target: HK$170.00): 1QFY26: Better-than-expected CMR and cloud revenue growth; encouraging quick commerce outlook. BYD Company (1211 HK/SELL/HK$114.40/Target: HK$90.00): 2Q25: Earnings down over 30% yoy/qoq, missing estimates on margins. Downgrade from BUY to SELL. Cut target price from HK$142.00 to HK$90.00. BYD Electronic (285 HK/BUY/HK$41.18/Target: HK$51.80): 1H25: Margin misses due to product mix shift; growth story remains unchange...
GREATER CHINA Strategy Alpha Picks: August Conviction Calls: Add JBM Healthcare and Lenovo to our BUY list. Take profit on CATL, Han’s Laser, KE Holdings and Longfor. INDONESIA Strategy Alpha Picks: Underperformance In July: Our new Alpha Picks are ASSA, AKRA, ARCI, BBNI, KLBF, MTEL, and MYOR. MALAYSIA Strategy Alpha Picks: Some Opportunities Amid A “Summer Lull”: Our July 25 Alpha Picks outperformed. Aug 25 picks: Coraza, Eco World, Gamuda, Hume Cement, IJM, Inari, RHB and Zetrix. SINGAPORE ...
GREATER CHINA Strategy Alpha Picks: July Conviction Calls: Add CATL, KE Holdings, Longfor, Midea Group, Tencent and TME to our BUY list. Take profit on Prudential. INDONESIA Strategy Alpha Picks: Good Performances In June: Our new Alpha Picks are ANTM, BBCA, ERAA, ICBP, MYOR, MIKA, AMRT and TLKM. MALAYSIA Strategy Alpha Picks: Positioning For Positive US Trade Deals: Our Jun 25 Alpha Picks outperform. Jul 25 picks: Coraza, Duopharma, Eco World, Gamuda, Hume Cement, IJM, Inari and MYEG. SINGAP...
GREATER CHINA Strategy Alpha Picks: June Conviction Calls: Add Prudential and Sino Biopharm to our BUY list. Take profit on SHKP and Trip.com. INDONESIA Strategy Alpha Picks: Good Performances In May: Good performances from most with the exception of GOTO and BUKA. MALAYSIA Strategy Alpha Picks: Raising Emphasis On Infrastructure Plays: Our May 25 Alpha Picks outperformed with resounding success. June 25 picks: Duopharma, Eco World, Gamuda, Hume Cement, IJM, MYEG, Northeast Group. SINGAPORE S...
GREATER CHINA Strategy Alpha Picks: May Conviction Calls: Add Alibaba, Innovent, Shuanghuan, Trip.com to our BUY list. Take profit on JBM Healthcare and CR Land. INDONESIA Strategy Alpha Picks: Outperformance In Apr 25: Remove ICBP, EXCL and MIKA; add BBTN and GOTO. MALAYSIA Strategy Alpha Picks: Capitalising On Sentiment Turnaround: Our Apr 25 Alpha Picks underperformed. May 25 picks: Duopharma, Gamuda, IJM, IOI Properties, TIME dotCom, MYEG, Nationgate, Northeast Group and RHB Bank. SINGAPO...
In 1Q25, core net profit grew 0.8% yoy, driven by: a) a 1.1% increase in revenue, b) lower net finance cost and R&D expenses, c) a 24.7% yoy growth in investment income, and d) higher credit impairment reversal. Gross margin decreased 0.2ppt yoy to 7.8%. OCF was -Rmb95.9b, improving from -Rmb96.6b in 1Q24. Debt-to-asset ratio decreased 0.1ppt qoq to 75.5%. For 2025, CSCEC targets high quality developments with better OCF and lower debt ratio. Trim earnings forecast. Maintain BUY. Target price: R...
KEY HIGHLIGHTS Sector Online Travel Agencies We saw continuous vitality in cultural and tourism consumption based on 1Q25 travel data and Labour Day travel data projections. Key travellers’ preference trends during Labour Day 2025 will be long-haul travel, inbound tourism and county-level travel. With favourable policy support such as the implementation of "instant tax refunds" for outbound travel, we expect to see promising revenue and earnings growth from OTA companies in 1H25. Maintain OVER...
GREATER CHINA Sector Online Travel Agencies: Travel data preview: Expecting a vibrant 2025 Labour Day Results BYD Electronic (285 HK/BUY/HK$31.80/Target: HK$41.20): 1Q25: Margins below expectations; automotive business to lead the charge in 2025. Maintain BUY. China Resources Building Materials Technology (1313 HK/BUY/HK$1.69/Target: HK$2.30): 1Q25: In line; severe drought in Guangxi restricts cement products outflow. China State Construction Engineering Corporation (601668 CH/BUY/Rmb5.49 /Targe...
In 2024, although net profit fell 14.9% yoy and is 6.9% below our estimate, the stable gross margin, higher dividend payout ratio and significant cash flow improvement in 4Q24 are major highlights, reflecting CSCEC’s competitiveness in a challenging environment. The company targets stable DPS in 2025. Potential fiscal stimulus to stable domestic demand will support CSCEC’s IC order growth and cash collection. Trim 2025/26 forecasts by 5.3%/8.4%. Maintain BUY. Target price: Rmb6.61.
GREATER CHINA Economics Economic Activity: 1Q25 growth tops estimates as stimuli gain traction. Strategy Small-Mid Cap Monthly: Sidestepping Trump’s tariffs: Prefer domestic names. Top pick: JBM Healthcare. Sector Automobile: Weekly: PEV sales surge continues, BYD leads as competition escalates. Maintain MARKET WEIGHT on the sector. Top BUYs: BYD, Geely and Desay SV. Results China State Construction Engineering Corporation (601668 CH/BUY/Rmb5.48 /Target: Rmb6.61): 2024 earnings below expectation...
GREATER CHINA Strategy Alpha Picks: April Conviction Calls: Add CR Beer, Desay, JBM Healthcare, JD Logistics, Minth, WuXi App Tech and Xiaomi Corp to our BUY list. Take profit on AIA, Hansoh Pharma, JD and Zijin Mining. INDONESIA Strategy Alpha Picks: Outperform In Mar 25: Remove BBNI, BBRI, ASII, JSMR and KLBF; add BBCA, ICBP, ERAA and BUKA. MALAYSIA Strategy Alpha Picks: Pockets of Opportunities: Our Mar 25 Alpha Picks outperform. Apr 25 picks: Alpha IVF, Duopharma, IJM, IOI Properties, TIME...
GREATER CHINA Strategy Alpha Picks: March Conviction Calls: Add Geely, JD, SHKP and Zijin Mining to our BUY list. Take profit on CATL, Desay, JD Logistics, Mengniu, Plover Bay and Tencent. INDONESIA Strategy Alpha Picks: Underperformance In Feb 25: Our picks are BBNI, BBRI, MIKA, EXCL, KLBF, JSMR and ASII. MALAYSIA Strategy Alpha Picks: Unprecedented Combo Of Disappointments: Our Feb 25 Alpha Picks sorely underperformed. Mar 25 picks: 99SpeedMart, Alpha IVF, KPJ Healthcare, MrDIY, MYEG, RHB Ba...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.